JP2017512762A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512762A5
JP2017512762A5 JP2016555478A JP2016555478A JP2017512762A5 JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5 JP 2016555478 A JP2016555478 A JP 2016555478A JP 2016555478 A JP2016555478 A JP 2016555478A JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5
Authority
JP
Japan
Prior art keywords
hexafluorophosphate
acid
compound
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016555478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512762A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072267 external-priority patent/WO2015134096A1/en
Publication of JP2017512762A publication Critical patent/JP2017512762A/ja
Publication of JP2017512762A5 publication Critical patent/JP2017512762A5/ja
Pending legal-status Critical Current

Links

JP2016555478A 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法 Pending JP2017512762A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461947286P 2014-03-03 2014-03-03
US61/947,286 2014-03-03
PCT/US2014/072267 WO2015134096A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (2)

Publication Number Publication Date
JP2017512762A JP2017512762A (ja) 2017-05-25
JP2017512762A5 true JP2017512762A5 (enExample) 2018-02-08

Family

ID=54055710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016555478A Pending JP2017512762A (ja) 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法

Country Status (7)

Country Link
US (1) US20170081363A1 (enExample)
EP (1) EP3114136A4 (enExample)
JP (1) JP2017512762A (enExample)
CN (1) CN106459169A (enExample)
CA (1) CA2942143A1 (enExample)
HK (1) HK1231493A1 (enExample)
WO (1) WO2015134096A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112457368A (zh) 2013-12-27 2021-03-09 康德生物医疗技术公司 药学相关的芳香族阳离子肽
JP6854771B2 (ja) 2015-03-06 2021-04-07 ステルス バイオセラピューティックス コープ 薬学的に適切なペプチドを調製するための方法
JPWO2017043626A1 (ja) * 2015-09-11 2018-06-21 株式会社カネカ 光学活性4−カルバモイル−2,6−ジメチルフェニルアラニン誘導体の製造法
CA3020393A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
EP3606938A1 (en) 2017-04-05 2020-02-12 Stealth BioTherapeutics Corp Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
WO2019099481A1 (en) * 2017-11-15 2019-05-23 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
KR20210093958A (ko) 2018-12-18 2021-07-28 스텔스 바이오테라퓨틱스 코포레이션 미토콘드리아 질환을 표적으로 하는 유사체
WO2023132352A1 (ja) * 2022-01-06 2023-07-13 中外製薬株式会社 アミド化合物の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1294403A2 (en) * 2000-06-14 2003-03-26 Corixa Corporation Tripeptide prodrug compounds
ES2694574T3 (es) * 2003-05-01 2018-12-21 Cornell Research Foundation, Inc. Método y complejos portadores para suministrar moléculas a células
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3040080A1 (en) * 2010-03-15 2016-07-06 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
US20150118315A1 (en) * 2011-06-14 2015-04-30 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
EP3281634A1 (en) * 2012-02-22 2018-02-14 Stealth Peptides International, Inc. Method and compositions for preventing or treating ophthalmic conditions
US20130303436A1 (en) * 2012-12-06 2013-11-14 Stealth Peptides Internatioanl, Inc. Peptide therapeutics and methods for using same

Similar Documents

Publication Publication Date Title
JP2017512762A5 (enExample)
JP2017502956A5 (enExample)
KR101514953B1 (ko) 매크로사이클릭 화합물의 제조방법
ES2552338T3 (es) Compuestos farmacéuticos
CN106459087B (zh) 活化的凝血因子X (FXa)抑制剂的制备方法
EP3645529B1 (en) Process for preparing lifitegrast and intermediates thereof
AU2008346833A1 (en) Process for preparing N-substituted hydroxypyrimidinone carboxamides
JP7450572B2 (ja) 薬学的に適切なペプチドを調製するための方法
JP7377307B2 (ja) 1-(4-(4-(3,4-ジクロロ-2-フルオロフェニルアミノ)-7-メトキシキナゾリン-6-イルオキシ)ピペリジン-1-イル)プロパ-2-エン-1-オンの製造方法
JP2016535081A5 (enExample)
CA2801101A1 (en) Process for preparing a biphenyl-2-ylcarbamic acid
ES2715082T3 (es) Método de producción de un pentapéptido sintético
JP2017512762A (ja) 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法
RU2717830C2 (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
CN107810189B (zh) 用于制备氮芥衍生物的方法
ES2791187T3 (es) Síntesis de dabigatrán
KR102742083B1 (ko) 디메톡시벤젠 화합물의 제조 방법
CN114667136A (zh) Trofinetide的组合物
KR20150067175A (ko) 보르테조밉을 제조하기 위한 방법
RU2009143867A (ru) Способы получения производных n-изобутил-n-(2-гидрокси-3-амино-4-фенилбутил)-пара-нитробензолсульфониламида
KR101578979B1 (ko) 라코사마이드의 제조방법
ES2827459T3 (es) Procedimiento para la preparación de apixaban
US10329325B2 (en) Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
US20240002432A1 (en) Method for producing amino acid or peptide, protective group-forming reagent, and compound
WO2013064451A1 (en) Novel process for the preparation of acylguanidines and acylthioureas